Leishmania panamensis on the foot
Leishmania panamensis on the foot
Leishmania panamensis - close-up
Leishmania panamensis - close-up
Antibodies
Antibodies

Leishmaniasis

Definition:
Leishmaniasis is a parasitic disease spread by the bite of the sandfly.

Alternative Names:
Kala-azar

Causes, incidence, and risk factors:

Leishmania are tiny protozoa. Their parasitic life cycle includes the sandfly and an appropriate host. Humans are one of those hosts. Leishmania infection can cause skin disease (called cutaneous leishmaniasis).

It can affect the mucous membranes with a wide range of appearance, most frequently ulcers. It may cause skin lesions that resemble those of other diseases including cutaneous tuberculosis, syphilis, leprosy, skin cancer (basal cell carcinoma), and fungus infections.

Leishmania can also cause systemic disease (visceral leishmaniasis) with fatal complications. When introduced into the body by the bite of a sandfly, the parasite migrates to the bone marrow, spleen, and lymph nodes.

Systemic infection in children usually begins suddenly with vomiting, diarrhea, fever, and cough. In adults, fever for 2 weeks to 2 months is accompanied by nonspecific symptoms, such as fatigue, weakness, and loss of appetite. Weakness increases as the disease progresses.

The skin may become grayish, dark, dry, and flaky. The parasites damage the immune system by decreasing the numbers of disease-fighting cells so death usually results from complications (such as other infections) rather than from the disease itself. Death often occurs within 2 years.

Cases of infection by Leishmania have been reported on all the continents except Australia. In the Americas, Leishmania can be found from Mexico south into the South American continent. Leishmaniasis has been reported among some military personnel returning from the Persian Gulf. (See Travelers guide to avoiding infectious diseases.)

Symptoms:
  • history of exposure to the bite of sandflies
  • history in being in an area known for leishmaniasis

Systemic illness (visceral leishmaniasis)

Skin disease (cutaneous leishmaniasis)
Symptoms on the skin include:

  • macule or papule, erythematous
  • skin ulcer, forms at site of original lesion
  • ulcer heals very slowly over a matter of months
  • smaller lesions may form around the ulcer (satellite lesions)

Symptoms on mucous membranes include:

Signs and tests:

SIGNS

TESTS
Systemic disease:

Other tests (complementary to the diagnosis)

Treatment:

Antimony-containing compounds are the principal medications used to treat leishmaniasis. These include:

  • meglumine antimonate
  • sodium stibogluconate

Other drugs that may be used include:

  • pentamidine
  • amphotericin B

Plastic surgery may be required to correct disfigurement by destructive facial lesions (mucocutaneous leishmaniasis). Removal of the spleen (splenectomy) may be required in drug-resistant cases (visceral leishmaniasis).

Expectations (prognosis):

Cure rates are high with antimony compounds. Treatment should be accomplished before damage to the immune system occurs. Marked disfigurement may develop with mucocutaneous leishmaniasis.

Complications:
  • facial disfigurement
  • fatal infections resulting from damage to the immune system
  • hemorrhage
Calling your health care provider:

Contact your health care provider if you have been in an area endemic for Leishmania and may have been bitten by sandflies, and now have symptoms suggestive of leishmaniasis.

Prevention:

Preventing sandfly bites is the most immediate form of protection. Insect repellent, appropriate clothing, screening of windows, and fine mesh netting around the bed (in endemic areas) will reduce exposure.

Public health measures to reduce the sandfly population and animal reservoirs are important. There are no preventive vaccines or drugs for leishmaniasis.


Review Date: 2/27/2002
Reviewed By: Camille Kotton, M.D., Infectious Diseases Division, Massachusetts General Hospital and Brigham and Women's Hospital, Boston, MA. Review provided by VeriMed Healthcare Network.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2003 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.